Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

US Approved Rx

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1992

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Protein

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

1

ChEMBL

1

DAILYMED

1

DRUG BANK

1

DRUG CENTRAL

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

IMMUNOSTIMULANTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

IMMUNOSTIMULANTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Interleukins

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

1

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "VATC|IMMUNOSTIMULANTS|IMMUNOSTIMULANTS|Interleukins|aldesleukin" in comments (approximate match)

Showing 1 - 1 of 1 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

ALDESLEUKIN

M89N0Q7EQR

Subunit 1 (132) Similarity Search

Export Data
Sequence Search

Subunit 1 (132) Similarity Search

Status:

US Approved Rx (1992)

First approved in 1992

Class:

PROTEIN

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1